Literature DB >> 28449529

Do hospitals need oncological critical care units?

Abby Koch1, William Checkley1.   

Abstract

Since the inception of critical care as a formal discipline in the late 1950s, we have seen rapid specialization to many types of intensive care units (ICUs) to accommodate evolving life support technologies and novel therapies in various disciplines of medicine. Indeed, the field has expanded such that specialized ICUs currently exist to address critical care problems in medicine, cardiology, neurology and neurosurgery, trauma, burns, organ transplant and cardiothoracic surgeries. Specialization does not only need new infrastructure, but also training and staffing of health care providers, ancillary staff, and development and implementation of processes of care. Oncology is another branch of medicine with growing ICU needs. Given the rise in cancer incidence worldwide and better survival rates alongside advances in chemotherapeutic and surgical options, more cancer patients are nowadays requiring advanced life support for cancer-related complications, treatment-related toxicities and severe infections. Here we provide a brief summary of the current evidence supporting the specialization of critical care and explore three different models of care for critically ill cancer patients, including the development of a specialized oncological ICU. Finally, we also discuss recently published and future research related to the care of critically ill cancer patients.

Entities:  

Keywords:  Cancer; oncology; process improvement; protocols; specialty intensive care units

Year:  2017        PMID: 28449529      PMCID: PMC5394060          DOI: 10.21037/jtd.2017.03.11

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  35 in total

Review 1.  Do intensivist staffing patterns influence hospital mortality following ICU admission? A systematic review and meta-analyses.

Authors:  M Elizabeth Wilcox; Christopher A K Y Chong; Daniel J Niven; Gordon D Rubenfeld; Kathryn M Rowan; Hannah Wunsch; Eddy Fan
Journal:  Crit Care Med       Date:  2013-10       Impact factor: 7.598

2.  Empirical Antifungal Therapy in Critically Ill Patients With Sepsis: Another Case of Less Is More in the ICU.

Authors:  Trishul Siddharthan; Petros C Karakousis; William Checkley
Journal:  JAMA       Date:  2016-10-18       Impact factor: 56.272

3.  Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia.

Authors:  J O Robinson; S Pozzi-Langhi; M Phillips; J C Pearson; K J Christiansen; G W Coombs; R J Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-03       Impact factor: 3.267

4.  Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage.

Authors:  M N Diringer; D F Edwards
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

5.  Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

Authors:  Jarushka Naidoo; Xuan Wang; Kaitlin M Woo; Tunc Iyriboz; Darragh Halpenny; Jane Cunningham; Jamie E Chaft; Neil H Segal; Margaret K Callahan; Alexander M Lesokhin; Jonathan Rosenberg; Martin H Voss; Charles M Rudin; Hira Rizvi; Xue Hou; Katherine Rodriguez; Melanie Albano; Ruth-Ann Gordon; Charles Leduc; Natasha Rekhtman; Bianca Harris; Alexander M Menzies; Alexander D Guminski; Matteo S Carlino; Benjamin Y Kong; Jedd D Wolchok; Michael A Postow; Georgina V Long; Matthew D Hellmann
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

6.  Protocols and Hospital Mortality in Critically Ill Patients: The United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study.

Authors:  Jonathan E Sevransky; William Checkley; Phabiola Herrera; Brian W Pickering; Juliana Barr; Samuel M Brown; Steven Y Chang; David Chong; David Kaufman; Richard D Fremont; Timothy D Girard; Jeffrey Hoag; Steven B Johnson; Mehta P Kerlin; Janice Liebler; James O'Brien; Terence O'Keefe; Pauline K Park; Stephen M Pastores; Namrata Patil; Anthony P Pietropaoli; Maryann Putman; Todd W Rice; Leo Rotello; Jonathan Siner; Sahul Sajid; David J Murphy; Greg S Martin
Journal:  Crit Care Med       Date:  2015-10       Impact factor: 7.598

Review 7.  The immunocompromised oncohematological critically ill patient: considerations in severe infections.

Authors:  Belén Encina; Leonel Lagunes; Marc Morales-Codina
Journal:  Ann Transl Med       Date:  2016-09

8.  Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit.

Authors:  Kathryn Jackson; Peter Mollee; Kirk Morris; Jason Butler; Dwane Jackson; Peter Kruger; Kerenaftali Klein; Glen Kennedy
Journal:  Leuk Lymphoma       Date:  2013-05-29

9.  Structure, process, and annual ICU mortality across 69 centers: United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study.

Authors:  William Checkley; Greg S Martin; Samuel M Brown; Steven Y Chang; Ousama Dabbagh; Richard D Fremont; Timothy D Girard; Todd W Rice; Michael D Howell; Steven B Johnson; James O'Brien; Pauline K Park; Stephen M Pastores; Namrata T Patil; Anthony P Pietropaoli; Maryann Putman; Leo Rotello; Jonathan Siner; Sahul Sajid; David J Murphy; Jonathan E Sevransky
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

Review 10.  Pharmacist contributions as members of the multidisciplinary ICU team.

Authors:  Candice R Preslaski; Ishaq Lat; Robert MacLaren; Jason Poston
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.